TARO PHARMACEUTICALS CANADA
Sonal Bansal holds a Master of Pharmacy in Pharmaceutics from Delhi University and has extensive experience in regulatory affairs within the pharmaceutical industry. Currently serving as a Senior Regulatory Affairs Associate at Taro Pharmaceuticals Canada since September 2021, Sonal previously worked as a Regulatory Affairs Associate at Mint Pharmaceuticals and held the position of Regulatory Affairs Manager at Sun Pharma and Ranbaxy. Notably, during the tenure at Ranbaxy, Sonal was selected for an international assignment in Moscow, where collaboration with external regulatory consultants led to the development of a regulatory framework. Sonal's career commenced at Ranbaxy as a Regulatory Affairs Associate, focusing on drug formulations. Education includes a Bachelor's degree in Pharmaceutical Sciences from Delhi University and a foundational secondary and high school education from The Mother's International School.
This person is not in any teams
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.